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Summary
Background: In outpatient settings diagnostic classifica-
tion of depressive symptoms is mostly descriptive based 
on ICD-10. Depending on clinical experience and consul-
tation time, diagnosis can be verified by validated scales. 
However, physicians working in primary care are famil-
iar with ICD-10 criteria. Therefore, the aim of the present 
study was to examine the feasibility of the validation of 
an ICD-10-derived symptom scale for depression. Meth-
ods: For this preliminary trial we generated a symptom 
scale derived 1:1 from the diagnostic criteria for depres-
sion given in the ICD-10 with 10 items. The Hamilton Rat-
ing Scale for Depression (HAMD-17) was used as refer-
ence in a population of 226 outpatients suffering from 
depressive symptoms. Correlation between scales as 
well as sensitivity and specificity of the ICD-10 scale 
were calculated. Results: The generated ICD-10 symp-
tom scale for depression could be analyzed in 219 pa-
tients and showed a significant and strong correlation 
with the HAMD-17 (p < 0.0001; ??= 0.75). The best trade-
offs between specificity and sensitivity of the ICD-10 
score were found at 10 points for the lower and 14 points 
for the upper cut-off. Overall sensitivity and specificity 
was 76.7 and 88.6%. Almost two thirds (i.e. 65.3%) of the 
patients were correctly classified by the ICD-10 scale. 
Conclusion: The ICD-10 symptom scale examined in the 
current population was found to have fair correlation 
with the HAMD-17 as well as, in face of the limited vari-
ance of the patients’ condition, acceptable sensitivity 
and specificity. Therefore, this preliminary study showed 
that the ICD-10-derived symptom scale seems appropri-
ate to be investigated in a thorough validation trial.
Schlüsselwörter
ICD-10-Score · HAMD-17 · Depression · Affektive Störung
Zusammenfassung
Hintergrund: Im ambulanten Medizinbereich erfolgt die 
diagnostische Einteilung depressiver Symptome meist 
deskriptiv nach ICD-10. Die Diagnose kann in Abhängig-
keit von klinischer Erfahrung und Konsultationsdauer mit 
etablierten Messinstrumenten verifiziert werden. Aller-
dings sind Kliniker mit dem ICD-10 vertraut. Daher war 
es das Ziel der vorliegenden Studie, die Durchführbarkeit 
der Validierung einer nach ICD-10-Kriterien generierten 
Skala zu analysieren. Methode: Für eine vorläufige 
 Studie wurde anhand der diagnostischen Kriterien für 
Depression im ICD-10 1:1 eine Symptomskala generiert. 
Die Korrelation wurde mittels des HAMD-17 als Refe-
renzskala an 226 ambulanten Patienten analysiert. Zu-
sätzlich wurden Sensitivität und Spezifität als auch die 
Cut-off-Werte berechnet. Ergebnisse: Die generierte 
ICD-10-Symptomskala für depressive Symptome konnte 
für 219 Patienten ausgewertet werden und zeigte eine 
 signifikante und starke Korrelation mit dem HAMD-17 
(p < 0,0001; ? = 0,75). Die besten «Trade-Offs» zwischen 
Spezifität und Sensitivität lagen bei 10 Punkten für den 
unteren und 14 Punkten für den oberen Cut-Off. Insge-
samt betrugen Sensitivität und Spezifität 76,7 und 88,6%. 
Fast zwei Drittel (65,3%) der Patienten wurde mit der 
ICD-10-Skala korrekt klassifiziert. Schlussfolgerung: Die 
untersuchte ICD-10-Symptomskala zeigte in der vorlie-
genden Population gute Ergebnisse bezüglich Korrela-
tion mit dem HAMD-17 sowie Sensitivität und Spezifität. 
Daher zeigt diese vorläufige Studie, dass sich diese ICD-
10-Symptomskala für eine umfassende Validierungs-
studie eignet. 
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Manual for Mental Disorders DSM-III-R [17] or the Symp-
tom Checklist SCL-90 [7].
Therefore, it was of particular interest for us to examine 
the feasibility in a population of outpatients with depressive 
syndrome, whether and if so to which extent the symptoms 
listed in the ICD-10 correlate with a validated instrument to 
corroborate the rationale for thorough validation trial. The 
data presented herein are preliminary and investigate the cor-
relation with another validated scale widely used in patients 
with depressive symptoms, the Hamilton Rating Scale for 
 Depression in its 17-item version (HAMD-17). The results of 
the open trial on efficacy and safety of the intervention with a 
drug from St. John’s wort in a community-based outpatient 
setting (n = 1,541) in which the ICD-10-derived scale had also 
been tested have been published elsewhere [18].
Methods
In a subpopulation of an open study [18], 40 investigators (i.e. GPs, neu-
rologists, psychiatrists) used HAMD-17 next to the constructed ICD-10 
scale to evaluate the feasibility for validation. Patients had to be ≥ 18 
years old, understand German sufficiently, and give consent to 
participate.
The reference scale, the HAMD-17, is a multiple choice questionnaire 
with 17 questions for detecting symptoms of major depression such as de-
pressed mood, guilt, suicide agitation, loss of weight etc. The clinician 
rates the responses to each question by interviewing the patient and ob-
serving the symptoms. Depending on the questions 3–5 possible answers 
are available to rate the severity of the depression. Interpretation of the 
total score varies according to different recommendations (e.g. 0–7 = nor-
mal; 8–13 = mild depression; 14–18 = moderate depression; 19–22 = se-
vere depression and ≥23 = very severe depression).
The test-scale, the ICD-10 symptom scale for depression (ICD-10-D) 
was derived 1:1 from the diagnostic criteria for depression given in the 
ICD-10 chapter of affective disorders (depressive syndrome, F32–F34) 
[19] to generate a symptom scale. The 10 criteria employed for construc-
tion were lowering of mood, loss of interest, lack of energy, reduction 
of self-esteem and self-confidence, ideas of guilt or worthlessness, sui-
cidal thoughts, difficulty in concentrating or thinking, psychomotor 
 retardation or agitation, disturbed sleep, altered appetite (table 1). For 
severity rating, a 5-point Likert scale was used ranging from 0 = absent 
to 4 = very severe for each symptom. For the ICD-10-D the total sum 
score was used.
Introduction
The prevalence of depression in clinics and in general prac-
tices is around 10–25% for women, 5–12% for men and 75–
80% for patients experiencing recurrent depression [1–3]. 
Consequently it is most likely that general practitioners (GPs) 
and specialists face patients with depressive symptoms among 
their weekly outpatients.
Yet, GPs are said to fail to diagnose 50% of depressed out-
patients [4]. Even in research the screening for depression 
with valid instruments has demonstrated only limited benefit 
[5]. In daily practice one might doubt if a lack of knowledge 
or availability of numerous valid instruments [6–11], widely 
known among specialists, is the problem or rather the lack of 
time needed for the correct administration of instruments in 
the face of limited resources. Yet, one would have to admit 
that even among psychiatrists the discussion which question-
naire should be used remains lively discussed [12, 13].
Nevertheless, patients, physicians, and health insurances 
are interested in quality of medical care, although from differ-
ent viewpoints. Next to the effort to improve therapy accord-
ing to evidence-based medicine (EbM), the evaluation of the 
efficacy of treatment is important for patients, physicians and 
increasingly also for health insurances. Notwithstanding, the 
first impression of the physician during clinical examination is 
one of the earliest diagnostic criteria to find out the medical 
state of the patient.
Unfortunately, the increasing economic pressure has en-
tered the medical system as well, and although this rises many 
ethical questions [14], time for the patient is often short and 
the administration of time-consuming validated rating scales 
seems often hardly possible [7, 12]. Yet, for classification of 
depressive symptoms in daily practice and for communication 
between physicians the ICD-10 is a worldwide used system 
[15]. Within the ICD-10 the operational diagnostic criteria for 
depressive syndromes are a special case as they cover criteria 
mentioned in existing validated questionnaires. They have 
been applied in evalutating outpatients, showed good con-
cordance in diagnosis between GPs as well as psychiatrists 
[16], and correlated well with the Diagnostic and Statistical 
Symptoms Rating, %
0 = absent 1 = mild 2 = moderate 3 = severe 4 = very severe
Lowering of mood  0.9 11.1 57.1 31.0 0.0
Loss of interest  9.3 23.6 42.2 24.0 0.9
Lack of energy  9.3 23.0 46.9 20.8 0.0
Reduction of self-esteem and self-confidence 17.7 15.0 38.9 28.3 0.0
Ideas of guilt or worthlessness 24.8 28.3 29.2 17.7 0.0
Suicidal thoughts 66.8 20.4  6.2  6.2 0.4
Difficulty concentrating or thinking 13.7 38.5 31.4 15.5 0.9
Psychomotor retardation or agitation 33.2 31.9 24.3 10.2 0.4
Disturbed sleep  6.7 23.1 39.6 30.7 0.0
Altered appetite 33.3 28.9 25.8 11.6 0.4
Table 1. ICD-10-D 
and patients’ rating 
(%)
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months (13.88 ± 28.07 months). Their main demographic data 
are summarized in table 2.
For validation of the ICD-10 scale n = 219 patients could be 
analyzed. The ICD-10 scale for depression showed a signifi-
cant and strong correlation with the HAMD-17 (p < 0.0001; 
? = 0.75; fig. 1). Yet, ? was weaker in the sub-scores HAMD 
1–7 including the depression triad (depressed mood, guilt, sui-
cidal thought) [10] and 8–17 including symptoms with an often 
co-morbid impact (e.g. anxiety, somatic, hypochondriac symp-
To differentiate the depressive symptoms of the patients, we exam-
ined other common psychiatric co-morbidities often related with depres-
sion (i.e. somatic symptoms of anxiety/depression, somatoform disorder, 
and anxiety). 
Statistics
Statistical analysis was performed with WinSTAT Version 2001.1 for 
Windows (SPSS-validated). The continuous data are presented as means, 
standard deviations (SD); additionally medians as well as 95% confidence 
intervals and numbers of patients were calculated. Categorical data are 
presented using counts and percentages rounded to one decimal place. 
All p-values are 2-tailed, and p < 0.05 was considered statistically 
significant.
Validity of the ICD-10 scale was examined by calculating the correla-
tion of the total score with the HAMD-17. For the correlation coefficient 
? ranging from –1 to 1, correlations between 0.5–1.0 were interpreted as 
strong. For the co-morbidities ? was also calculated.
Sensitivity and specificity of a quantitative test depend on the cut-off 
value above or below which the test is positive. In general, the higher the 
sensitivity, the lower the specificity, and vice versa.
Sensitivity = True positives / True positives + False negatives (1).
Specificity = True negatives / True negatives + False positives (2).
The testing of sensitivity and specificity of increasing lower and upper 
cut-offs of the ICD-10 scores versus the HAMD-17 as reference were cal-
culated manually, and the best trade-offs between specificity and sensitiv-
ity were chosen as cut-offs. The best trade-off between specificity and 
sensitivity was identified as the one yielding the highest value when calcu-
lating the product of specificity and sensitivity. Graphically, plotting spe-
cificity and sensitivity by increasing cut-offs, this point corresponds to the 
intersection of the 2 curves. For the current analysis we have employed 
the recommended cut-offs for the HAMD-17: lower limit = 8 and upper 
limit = 18 [12, 13].
Results
Of the 226 patients recruited (173 females, 46 males, 7 no 
data), 219 provided full sets of data and could be analyzed. In 
median their age was 49 years (mean ± SD 50.52 ± 14.70 
years) and they had a median duration of symptoms of 3 
Table 2. Demographics of participating patients
N %
Working status homework  62  27.4
part-time  31  13.7
full-time  61  27.0
retired  42  18.6
unemployed  24  10.6
no data   6   2.7
total 226 100.0
Duration of  
symptoms, months
< 1  57  25.2
1 to 3  60  26.5
3 to 12  55  24.3
12 to 24  25  11.1
24 to 240  28  12.4
no data   1   0.4
total 226 100.0
Age, years < 20   4   1.8
20 to 35  35  15.5
35 to 50  74  32.7
50 to 65  65  28.8
65 to 80  46  20.4
no data   2   0.9
total 226 100.0
Fig. 1. Correlation between HAMD-17 and 
ICD-10 sum score at admission (??= 0.75, 
p < 0.0001).
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Regarding the lower limit (i.e. distinguishing between de-
pression and normal) sensitivity was at 0.86 and specificity at 
0.89. However, the relevance of this assertion is limited by the 
small number of patients in the normal range in both the 
HAMD-17 and the ICD-10 scale (table 5). For the upper limit 
(i.e. distinguishing between mild to moderate depression and 
severe/very severe depression) sensitivity was at 0.80 and spe-
cificity at 0.77.
Discussion
In daily medical practice of the medical systems in the North-
ern hemisphere, physicians are confronted with different as-
pects of EbM in order to contribute to best possible clinical 
practice which primarily ought to serve the patient and sec-
ondly might limit health costs. EbM provides a basis to choose 
the right procedures which are necessary for a valid diagnosis 
of illnesses and efficacious treatment of patients. As health 
toms; table 3). However, in terms of psychiatric co-morbidi-
ties analyzed ? showed a rather good discrimination in favor 
of depression (depression ? 0.75 > somatic symptoms of anx-
iety/depression ??= 0.66 > somatoform disorder ??= 0.53 > 
anxiety ??= 0.20). 
The findings of the Clinical Global Impression Scale (CGI) 
rated by physicians as well as patients were in line with the 
findings of the ICD-10 and HAMD and have already been 
published just as the data for the Visual Analogue Scale 
(VAS) which correlated much weaker [18]. 
Testing for sensitivity and specificity by increasing lower 
and upper cut-offs of the tested ICD-10 scores versus HAMD-
17 scores is shown in figure 2 and 3. The best trade-offs be-
tween specificity and sensitivity of the ICD-10 score were 
found at 10 points for the lower and 14 points for the upper 
cut-off (mild depression).
65.3% of the patients were correctly classified by the ICD-
10 scale (table 4). However, the severity of the disorder was 
overestimated in 11.4% and underestimated in 23.3% of the 
patients. The overall sensitivity and specificity was 76.7% and 
88.6%.
HAMD (n = 219) ICD-10
1–17 
? 0.75
p-value < 0.0001
1–8 
? 0.74
p-value < 0.0001
9–17 
? 0.65
p-value < 0.0001
Table 3. Performance 
of ICD-10  criteria for 
depression chosen in 
terms of correlation 
with HAMD-17
Fig. 3. Testing sensitivity, specificity by increasing upper cut-offs of ICD-
10 scores. HAMD = reference, performance of ICD-10 criteria chosen.
Fig. 2. Testing sensitivity, specificity by increasing lower cut-offs of ICD-
10 scores. HAMD = reference, performance of ICD-10 criteria chosen.
Table 4. Agreement between individual ICD-10 and HAMD-17 scores 
(N and % of patients)
ICD-10 / HAMD-17 < 8 Within 8 to 18 > 18
< 10 8 (3.7%)a 29 (13.2%)b  3 (1.4%)b
Within 10 to 14 0 (0.0%)b 49 (22.4%)a 19 (8.7%)b
> 14 1 (0.5%)b 24 (10.9%)b 86 (39.2%)a
aScores agree.
bScores disagree.
Lower cut-offs
ICD-10/HAMD-17 >8 <8
>10 82.41%a 0.46%b
<10 13.43%b 3.70%a
Upper cut-offs
ICD-10/HAMD-17 >18 <18
>14 39.81%a 11.57%b
<14 10.19%b 39.81%a
aScores agree.
bScores disagree.
Table 5. Lower and 
upper cut-offs
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the difference between in- and outpatients might be more of 
scientific interest as they should not differ in depressive symp-
toms as such but in severity, which one would expect to be 
higher among inpatients. As a matter of fact, the current re-
sults can hardly be extrapolated on severely depressed 
patients.
The discussion about the use of the HAMD-17 [12, 13] 
shows a need not only for valid but also for widely accepted 
diagnostic instruments. The potential benefit of an ICD-10-
derived symptom scale could be that it provides non-psychia-
trists/GPs with an instrument that uses rather non-specialized 
termini which they are already trained to use as diagnostic cri-
teria within the ICD-10 and which they ought to use for docu-
mentation and inter-physician communication anyway. Inter-
estingly, a different ICD-10-derived scale, the ISR, has been 
developed and validated as a diagnostic tool for a variety of 
psychiatric disorders [7, 22]. For depression it is quite similar 
in terms of the 3 main symptoms of depression also covered 
by our scale. Thus, our scale (10 items) takes a kind of middle 
position in the number of depressive symptoms rated in the 
HAMD-17 (17 items) and the ISR (3 items). This underlines 
the need for evaluating an additional test instrument based on 
a generally accepted range of symptoms as well as being 
widely known and freely distributed and available. This 
should be a future goal not only for the rating of mental disor-
ders [25] but also for daily practice in our Western medical 
system itself in terms of rational medical care and easily avail-
able evaluation instruments for diagnosis and treatment 
response.
Conclusion
The ICD-10 symptom scale examined in the current popula-
tion was found to have fair correlation with the HAMD-17 as 
well as, in face of the limited variance of the patients’ condi-
tion, acceptable sensitivity and specificity. However, a rigor-
ous validation trial is necessary to corroborate these findings.
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costs seem to dominate not only political decisions in the 
medical system but also the choice of medical action (e.g. 
treatment, diagnosis), easily available diagnostic instruments 
become a precious value in the course of shared decision-
making and treatment [14].
Consequently, scales of diagnostic criteria that are already 
known to physicians, such as the ICD-10 criteria for depres-
sion which are generally used for documentation and referral, 
seem appropriate when they are valid in comparison with 
widely accepted scales such as the validated HAMD-17. To 
match both is highly rational and of great practical relevance. 
However, there is an ongoing discussion which depression 
scale could be seen as a gold standard [12, 13]. Additionally, 
the debate on inter-rater reliability accounts for the different 
valid questionnaires [6] and partly seems to be connected with 
clinical experience of physicians as such [8, 20]. This is a proof 
of the empirical knowledge on which medicine is based next 
to research evidence. Therefore, the idea to use a rating scale 
like the generated ICD-10-D seems reasonable in terms of the 
fact that physicians working in primary care are familiar with 
the ICD-10 itself. Moreover, the suitability of the ICD-10 cri-
teria for depression have been examined before among GPs 
[16] and have been found to be sufficiently stable. Only the 
diagnostic stability over time is discussed although this seems 
arbitrary and related to other factors than validity itself [21]. 
ICD-10 criteria for depression also have been used in valida-
tion studies for other scales, like the self-rated Hopkins Symp-
tom Checklist-10 (HSCL-10) [9] or the self-rated ICD-10 
symptom rating (ISR) [7, 22].
Nevertheless, there are limitations of this study. First of all, 
the study took place in a mixed physician group. One might 
argue that it would have been crucial to analyze inter-rater 
differences. On the one hand, we could not analyze this in the 
current preliminary study because patients were examined by 
one rater only. On the other hand, the ICD-10 criteria for de-
pression have already shown to have a good inter-rater relia-
bility in differentiating between depressed and non-depressed 
patients [23]. Secondly, the validation population is rather 
small and of limited variance of the patients’ condition as can 
be seen in table 4. Noteworthy, it has been pointed out that 
making a diagnosis for a condition would depend both on the 
discriminatory value of the test and the prevalence of the dis-
ease in the population of interest [24]. Under this premise the 
preliminary validation data of the examined ICD-10 scale 
seem fair concerning correlation, sensitivity and specificity in 
the population tested, and for the feasibility purpose of the 
study. But one would have to admit that the findings need to 
be validated in a rigorous validation study. Thirdly, one might 
point out that our population consisted of inpatients only. But 
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